•HRES 176 IH 
Whereas, although drugs, diagnostics and vaccines for TB 
exist, these technologies are antiquated and are increas-
ingly inadequate for controlling the global epidemic; 
Whereas the most commonly used TB diagnostic in the 
world, sputum microscopy, is more than 100 years old 
and lacks sensitivity to detect TB in most HIV/AIDS pa-
tients and in children; 
Whereas current tests to detect drug resistance take at least 
1 month to complete and faster drug susceptibility tests 
must be developed to stop the spread of drug resistant 
TB; 
Whereas the TB vaccine, BCG, provides some protection to 
children, but has little or no efficacy in preventing pul-
monary TB in adults; 
Whereas there is also a critical need for new TB drugs that 
can safely be taken concurrently with antiretroviral ther-
apy for HIV; 
Whereas enactment of the Tom Lantos and Henry J. Hyde 
United States Global Leadership Against HIV/AIDS, Tu-
berculosis, and Malaria Reauthorization Act of 2008 and 
the Comprehensive TB Elimination Act provide an his-
toric United States commitment to the global eradication 
of TB, including to the successful treatment of 4,500,000 
new TB patients and 90,000 new multi-drug resistant 
(MDR) TB cases by 2013, while providing additional 
treatment through coordinated multilateral efforts; 
Whereas the United States Agency for International Develop-
ment provides financial and technical assistance to nearly 
40 highly-burdened TB countries and supports the devel-
opment of new diagnostic and treatment tools, and is au-
VerDate Mar 15 2010 
00:37 Mar 18, 2011
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR176.IH
HR176
smartinez on DSKB9S0YB1PROD with BILLS
•HRES 176 IH 
thorized to support research to develop new vaccines to 
combat TB; 
Whereas the Centers for Disease Control and Prevention, 
working in partnership with States and territories of the 
United States, directs the national TB elimination pro-
gram and essential national TB surveillance, technical as-
sistance, prevention activities and supports the develop-
ment of new diagnostic, treatment and prevention tools 
to combat TB; 
Whereas the National Institutes of Health, through its many 
institutes and centers, plays the leading role in basic and 
clinical research into the identification, treatment and 
prevention of TB; 
Whereas the Global Fund to Fight AIDS, Tuberculosis and 
Malaria provides two-thirds of all international financing 
for TB programs worldwide and has supported the detec-
tion and treatment of 7,700,000 cases of TB; and 
Whereas March 24, 2011, is World Tuberculosis Day, a day 
that commemorates the date in 1882 when Dr. Robert 
Koch announced his discovery of Mycobacterium tuber-
culosis, the bacteria that causes tuberculosis: Now, there-
fore, be it 
Resolved, That the House of Representatives— 
(1) supports the goals of World TB Day to 
raise awareness about tuberculosis; 
(2) commends the progress made by United 
States-led anti-tuberculosis programs; and 
(3) reaffirms its commitment to global tuber-
culosis control made through the Tom Lantos and 
VerDate Mar 15 2010 
00:37 Mar 18, 2011
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\HR176.IH
HR176
smartinez on DSKB9S0YB1PROD with BILLS
•HRES 176 IH 
Henry J. Hyde United States Global Leadership 
Against HIV/AIDS, Tuberculosis, and Malaria Re-
authorization Act of 2008. 
Æ 
VerDate Mar 15 2010 
00:37 Mar 18, 2011
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\HR176.IH
HR176
smartinez on DSKB9S0YB1PROD with BILLS